Benefits of early lipid-lowering intervention in high-risk patients: The lipid intervention strategies for coronary patients study

Clinical Therapeutics

Volumn 22, Issue 8, 2000, Pages 949-960

  Pedersen, Terje R ^a   Jahnsen, Karin Eide ^a   Vatn, Sigurd ^a   Semb, Anne Grete ^a   Kontny, Frederic ^a   Zalmai, Akram ^a   Nerdrum, Tone ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

3 hydroxy 3 methylglutaryl coenzyme A reductase inhibitors; Acute coronary syndrome; Hypercholesterolemia; Prevention and control; Simvastatin

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET THERAPY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; UNSTABLE ANGINA PECTORIS;

EID: 0033864228     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80066-1     Document Type: Article

References (18)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
2. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
4. Prevention of coronary heart disease in clinical practice: A commentary on current treatment practices in six European countries in relation to published recommendations
5. Switching to statins: A challenge for primary care
6. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results
7. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel II)
9. Joint British recommendations on prevention of coronary heart disease in clinical practice: Summary
10. Long term experience with simvastatin
11. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge
12. After 4S, CARE and LIPID - Is evidence-based medicine being practised?
13. When to start cholesterol-lowering therapy in patients with coronary heart disease
14. Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease
15. Risk indicators for recurrence among patients with coronary artery disease. Problems associated with their modification
16. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
17. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
18. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease